Profiel
Michael R.
Goldberg joined Theravance, Inc. as Vice President of Clinical Pharmacology in September 2005.
From 1988 to 2005, he was Senior Director of Safety/Clinical Risk Management and Safety Surveillance for Merck and worked at Eli Lilly in the Clinical Pharmacology Department.
Dr. Goldberg received his MD and PhD degrees from Tulane University, School of Medicine and completed his Clinical Pharmacology fellowship at the Vanderbilt University School of Medicine.
Eerdere bekende functies van Michael R. Goldberg
| Bedrijven | Functie | Einde |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 01-01-2005 |
| INNOVIVA, INC. | Corporate Officer/Principal | - |
Opleiding van Michael R. Goldberg
| Tulane University (Louisiana) | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| INNOVIVA, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
